Tag: US regulatory

Innovation, Medical Devices

Abbott obtains US regulatory approval for HeartMate 3 device

October 22, 2018


The approval has labelled HeartMate 3 as a destination therapy for people who are not eligible for a transplant. LVADs are designed to pump blood through the body in order to significantly cut down the workload on a weakened heart. […]